Nilsine Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Buy |
3,725
+5
| +0.1% | +$2.23K | 0.17% | 134 |
|
|
2025
Q1 | $1.8M | Buy |
3,720
+516
| +16% | +$250K | 0.2% | 112 |
|
|
2024
Q4 | $1.29M | Buy |
3,204
+2
| +0.1% | +$805 | 0.14% | 162 |
|
|
2024
Q3 | $1.49M | Sell |
3,202
-248
| -7% | -$115K | 0.19% | 130 |
|
|
2024
Q2 | $1.62M | Sell |
3,450
-31
| -0.9% | -$14.5K | 0.22% | 116 |
|
|
2024
Q1 | $1.46M | Sell |
3,481
-71
| -2% | -$29.7K | 0.2% | 128 |
|
|
2023
Q4 | $1.45M | Sell |
3,552
-1,760
| -33% | -$716K | 0.22% | 118 |
|
|
2023
Q3 | $1.85M | Buy |
5,312
+1,093
| +26% | +$380K | 0.28% | 94 |
|
|
2023
Q2 | $1.48M | Buy |
4,219
+39
| +0.9% | +$13.7K | 0.22% | 114 |
|
|
2023
Q1 | $1.32M | Buy |
+4,180
| New | +$1.32M | 0.21% | 125 |
|